anurajms/meta_analysis huggingface dataset:
Interventions:
Slow versus fast subcutaneous heparin injections for prevention of bruising and site pain intensity
1. Unfractionated Heparin Therapy 2. Subcutaneous 3. Low Molecular Weight Heparin
Interventions:
Hybrid repair versus conventional open repair for thoracic aortic arch aneurysms
1. Surgical Repair 2. Endovascular insertion of stent
Interventions:
Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chronic heart failure with preserved ejection fraction
1. Neprilysin Inhibitor 2. Beta Blocking Agent 3. Usual Care 4. Angiotensin-converting enzyme inhibitor
Interventions:
Anticoagulation versus placebo for heart failure in sinus rhythm
1. Anticoagulant therapy
Interventions:
Vasodilators for primary Raynaud's phenomenon
1. Vasodilator Agents
Interventions:
Fludrocortisone for orthostatic hypotension
1. Fludrocortisone
Interventions:
Exercise‐based cardiac rehabilitation for adults after heart valve surgery
1. Exercise therapy 2. Psychoeducation
Interventions:
Endoluminal interventions versus surgical interventions for stenosis in vein grafts following infrainguinal bypass
1. Angioplasty Balloon Catheter 2. Stent
Interventions:
Thrombolytic therapy for pulmonary embolism
1. Heparin 2. Thrombolytic agent
Interventions:
Mobile phone‐based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults
1. Monitoring Adherence To Medication Regime 2. mHealth
Interventions:
Antibiotics for secondary prevention of coronary heart disease
1. Antibiotic Therapy
Interventions:
Surgical and radiological interventions for treating symptomatic extracranial cervical artery dissection
1. Medical Therapy 2. Surgery 3. Interventional Radiology
Interventions:
Long‐term effects of weight‐reducing drugs in people with hypertension
1. Topiramate 2. Bupropion 3. Rimonabant 4. Phentermine 5. Orlistat 6. Lorcaserin 7. Sibutramine 8. Naltrexone 9. Liraglutide
Interventions:
Blood pressure targets in adults with hypertension
1. Targeted Therapy
Interventions:
Trypanocidal drugs for late‐stage, symptomatic Chagas disease (Trypanosoma cruzi infection)
1. Nitrofuran Derivatives 2. Imidazole Derivatives
Interventions:
Angioplasty versus stenting for iliac artery lesions
1. Percutaneous Transluminal Angioplasty
Interventions:
Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome
1. Inotropic agent 2. Pulmonary Vasodilator
Interventions:
Ivabradine as adjuvant treatment for chronic heart failure
1. Ivabradine 2. Usual Care
Interventions:
Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension
1. Renin-inhibitors
Interventions:
Electromechanical‐assisted training for walking after stroke
1. Electromechanical-assisted Gait Training 2. Physiotherapy 3. Robotic-assisted Gait Training
Interventions:
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease
1. PCSK9 Inhibitor
Interventions:
Pentoxifylline for intermittent claudication
1. Pentoxifylline
Interventions:
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
1. Antiplatelet Agent Therapy 2. Anticoagulant therapy
Interventions:
Vena caval filters for the prevention of pulmonary embolism
1. Antithrombotic Agents 2. Prophylaxis 3. Vena Cava Filter 4. Anticoagulant therapy
Interventions:
Atherectomy for peripheral arterial disease
1. Atherectomy 2. Angioplasty Of Artery
Interventions:
Motor imagery for gait rehabilitation after stroke
1. Guided Fantasy Technique 2. Imagery Technique 3. Imagery Therapy
Interventions:
Presurgery exercise‐based conditioning interventions (prehabilitation) in adults undergoing lower limb surgery for peripheral arterial disease
1. Physical therapy exercises 2. Preoperative
Interventions:
Alcohol intake reduction for controlling hypertension
1. Alcohol Reduction Programme 2. Acamprosate 3. Benzodiazepine 4. Disulfiram 5. Nalmefene 6. Naltrexone
Interventions:
Time course for blood pressure lowering of beta‐blockers with partial agonist activity
1. Beta Blocking Agent
Interventions:
Citicoline for treating people with acute ischemic stroke
1. Choline 2. Citiolone
Interventions:
Modes of exercise training for intermittent claudication
1. Exercise therapy
Interventions:
Setting and techniques for monitoring blood pressure during pregnancy
1. Ambulatory Blood Pressure Recording 2. Blood Pressure Monitoring 3. Home
Interventions:
mHealth education interventions in heart failure
1. Health Promotion Education 2. Text Message 3. Computer delivered intervention
Interventions:
Effect of alcohol on blood pressure
1. Alcoholic Drink
Interventions:
Surgery for small asymptomatic abdominal aortic aneurysms
1. Prosthetic Graft Thrombectomy
Interventions:
Mechanical assist devices for acute cardiogenic shock
1. Circulatory Care: Mechanical Assist Device
Interventions:
Mental practice for treating upper extremity deficits in individuals with hemiparesis after stroke
1. Mental Practice
Interventions:
A comparison of different antibiotic regimens for the treatment of infective endocarditis
1. Antibiotic Therapy
Interventions:
Anti‐inflammatory therapy for preventing stroke and other vascular events after ischaemic stroke or transient ischaemic attack
1. Anti-inflammatory agents
Interventions:
Pharmacological, psychological and non‐invasive brain stimulation interventions for preventing depression after stroke
1. Non-invasive brain stimulation 2. Drug Therapy 3. Formal Psychological Therapy
Interventions:
Pharmacological treatment for Buerger's disease
1. Aspirin 2. Intravenous 3. Cilostazol 4. Oral 5. Prostanoids
Interventions:
Interventions for sexual dysfunction following stroke
1. Non-Pharmacological Interventions 2. Drug Therapy 3. Complementary Therapy
Interventions:
Transverse versus vertical groin incision for femoral artery approach
1. Transverse groin incision
Interventions:
Low molecular weight heparin for prevention of microvascular occlusion in digital replantation
1. Preventive 2. Subcutaneous 3. Low Molecular Weight Heparin
Interventions:
Treatment of distal deep vein thrombosis
1. Antithrombotic Agents 2. Compression Therapy
Interventions:
Physical fitness training for stroke patients
1. Exercise therapy
Interventions:
Advance care planning for adults with heart failure
1. Advance Care Planning
Interventions:
Carotid artery stenting versus endarterectomy for treatment of carotid artery stenosis
1. Insertion Of Carotid Artery Stent
Interventions:
Anticoagulant treatment for subsegmental pulmonary embolism
1. Anticoagulant therapy
Interventions:
First‐line combination therapy versus first‐line monotherapy for primary hypertension
1. Combination Therapy 2. Antihypertensive agents
Interventions:
Dressings and topical agents for arterial leg ulcers
1. Application Of Dressing 2. Topical
Interventions:
Motor neuroprosthesis for promoting recovery of function after stroke
1. Electrode 2. Neurostimulator 3. Prosthetic Implant 4. Electrical stimulation 5. Electromyography
Interventions:
Endovascular versus open repair of asymptomatic popliteal artery aneurysm
1. Endovascular Insertion Of Stent Graft
Interventions:
Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis
1. Antithrombotic Agents 2. Antiplatelet Agent Therapy
Interventions:
Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk
1. Transcatheter aortic valve replacement
Interventions:
Beta‐blockers for suspected or diagnosed acute myocardial infarction
1. Beta Blocking Agent 2. Medical Therapy 3. Heart Revascularization
Interventions:
Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure
1. Positive Pressure Therapy
Interventions:
Cognitive rehabilitation for attention deficits following stroke
1. Cognitive rehabilitation therapy
Interventions:
Combined proximal descending aortic endografting plus distal bare metal stenting (PETTICOAT technique) versus conventional proximal descending aortic stent graft repair for complicated type B aortic dissections
1. Distal Bare Metal Stenting 2. Insertion Of Proximal Extension Prosthesis For Repair Of Descending Thoracic Aorta
Interventions:
Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing non‐cardiac surgery
1. Beta Blocking Agent
Interventions:
Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing cardiac surgery
1. Beta Blocking Agent
Interventions:
Compression therapy for treating post‐thrombotic syndrome
1. Graduated Compression Elastic Hosiery 2. Compression Stockings 3. Compression Therapy
Interventions:
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
1. Oral 2. Antiarrhythmics, Class I And III
Interventions:
Interventions for visual field defects in people with stroke
1. Cortical Stimulation 2. Transcranial Direct Current Stimulation 3. Orthoptic Treatment - Fresnel Prisms
Interventions:
Stem cell transplantation for ischemic stroke
1. Stem Cell Transplantation
Interventions:
Prostacyclin for pulmonary arterial hypertension
1. Prostacyclin
Interventions:
Non‐invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema
1. Non-invasive positive pressure ventilation 2. Continuous Positive Airway Pressure Ventilation
Interventions:
Epidural analgesia for adults undergoing cardiac surgery with or without cardiopulmonary bypass
1. Perioperative 2. Epidural - Continuous Administration 3. Epidural Anesthesia 4. Epidural - single shot block
Interventions:
Calcium antagonists for acute ischemic stroke
1. Calcium Channel Blockers 2. Intravenous 3. Oral
Interventions:
Exercise‐based cardiac rehabilitation for adult patients with an implantable cardioverter defibrillator
1. Cardiac Rehabilitation 2. Exercise therapy
Interventions:
Thoracic endovascular repair (TEVAR) versus open surgery for blunt traumatic thoracic aortic injury
1. Thoracic endovascular repair
Interventions:
Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in‐stent restenosis of the femoropopliteal arteries
1. Drug-Eluting Balloon Angioplasty
Interventions:
Clinically‐indicated replacement versus routine replacement of peripheral venous catheters
1. Replacement Of Catheter
Interventions:
Disease management interventions for heart failure
1. Referral To Heart Failure Clinic 2. Case Management 3. Disease Management Program
Interventions:
Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb‐threatening ischaemia
1. Percutaneous Transluminal Angioplasty 2. Insertion Of Arterial Stent
Interventions:
Implantable cardiac defibrillators for people with non‐ischaemic cardiomyopathy
1. Implantation Of Automatic Cardioverter/defibrillator, Total System 2. Cardiac Resynchronisation Therapy Implantable Pacemaker
Interventions:
Ezetimibe for the prevention of cardiovascular disease and all‐cause mortality events
1. Lipid Modifying Agents 2. Ezetimibe
Interventions:
First‐line drugs inhibiting the renin angiotensin system versus other first‐line antihypertensive drug classes for hypertension
1. Calcium Channel Blockers 2. Alpha 2 adrenergic blocking agent 3. Beta Blocking Agent 4. Thiazides 5. Central nervous system agent
Interventions:
Stem cell therapy for treatment of thromboangiitis obliterans (Buerger's disease)
1. Stem Cell Therapy
Interventions:
Gamma aminobutyric acid (GABA) receptor agonists for acute stroke
1. Gamma-Aminobutyric Acid
Interventions:
Percutaneous vascular interventions versus intravenous thrombolytic treatment for acute ischaemic stroke
1. Thrombectomy Of Head And Neck Artery 2. Mechanical fragmentation 3. Thromboaspiration 4. Intra-arterial Sonothrombolysis
Interventions:
Very early versus delayed mobilisation after stroke
1. Early Treatment 2. Therapeutic mobilization
Interventions:
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
1. Antihypertensive agents
Interventions:
Exercise‐based cardiac rehabilitation for people with implantable ventricular assist devices
1. Cardiac Rehabilitation 2. Physical therapy exercises
Interventions:
Electromechanical and robot‐assisted arm training for improving activities of daily living, arm function, and arm muscle strength after stroke
1. Robotic Arm 2. Therapeutic Exercise
Interventions:
Mechanical versus manual chest compressions for cardiac arrest
1. Mechanically Assisted Chest Compression
Interventions:
Endovascular coiling versus neurosurgical clipping for people with aneurysmal subarachnoid haemorrhage
1. Endovascular coil embolization 2. Embolisation Coil
Interventions:
Surgery versus thrombolysis for initial management of acute limb ischaemia
1. Thrombolysis Of Artery
Interventions:
Activity monitors for increasing physical activity in adult stroke survivors
1. Telehealth Monitoring 2. Monitor 3. Smartphone app
Interventions:
Blood pressure‐lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack
1. Antihypertensive agents
Interventions:
Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non‐cardiac surgery
1. Surgery 2. Antiplatelet Agent Therapy
Interventions:
Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies
1. Antiplatelet agent 2. Anticoagulant therapy
Interventions:
Mirror therapy for improving motor function after stroke
1. Device
Interventions:
Remote ischaemic conditioning for preventing and treating ischaemic stroke
1. Remote Ischemic Preconditioning 2. Tourniquet Cuff 3. Ischemic Preconditioning 4. Blood Pressure Cuff
Interventions:
Controlled hypotension versus normotensive resuscitation strategy for people with ruptured abdominal aortic aneurysm
1. Intravenous 2. Hypotensive Resuscitation Strategy 3. Body Fluid Replacement
Interventions:
Extracorporeal shock wave therapy for the healing and management of venous leg ulcers
1. Extracorporeal Shock Wave Therapy
Interventions:
Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in people with coronary artery disease
1. Transradial Approach
Interventions:
First‐line drugs for hypertension
1. Calcium Channel Blockers 2. Beta Blocking Agent 3. ACE Inhibitors, Plain 4. Thiazides 5. Angiotensin II Antagonists, Plain 6. Alpha-adrenoreceptor Antagonists
Interventions:
Supervised exercise therapy versus home‐based exercise therapy versus walking advice for intermittent claudication
1. Exercise therapy 2. Hospital 3. Physical Therapist
Interventions:
Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity
1. Perioperative Care 2. Beta Blocking Agent
Interventions:
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
1. Parenteral 2. Oral 3. Direct Factor Xa Inhibitors
Interventions:
Fluvastatin for lowering lipids
1. Fluvastatin
Interventions:
Treatment for superficial thrombophlebitis of the leg
1. Symptom control therapy
Interventions:
Graft type for femoro‐popliteal bypass surgery
1. Grafting Procedure
Interventions:
Pulmonary artery perfusion versus no perfusion during cardiopulmonary bypass for open heart surgery in adults
1. Perfusion of Pulmonary Artery
Interventions:
Exercise‐based cardiac rehabilitation for adults with stable angina
1. Cardiac Rehabilitation 2. Physical therapy exercises
Interventions:
Antibiotic therapy for preventing infections in people with acute stroke
1. Intramuscular 2. Intravenous 3. Oral 4. Antibiotic Therapy
Interventions:
Prostanoids for critical limb ischaemia
1. Prostaglandin E series
Interventions:
Home versus in‐patient treatment for deep vein thrombosis
1. Low Molecular Weight Heparin Therapy 2. Home
Interventions:
Exercise for intermittent claudication
1. Exercise therapy
Interventions:
Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
1. Thromboprophylaxis 2. Oral
Interventions:
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events
1. Aspirin 2. Clopidogrel
Interventions:
Calcium channel blockers for primary and secondary Raynaud's phenomenon
1. Calcium Channel Blockers
Interventions:
Thrombolysis for acute upper extremity deep vein thrombosis
1. Thrombolytic agent 2. Anticoagulant therapy
Interventions:
Pentasaccharides for the treatment of deep vein thrombosis
1. Pentasaccharides
Interventions:
Virtual reality for stroke rehabilitation
1. Virtual Reality
Interventions:
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease
1. Oral 2. Anticoagulant therapy
Interventions:
Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia
1. Calcium Channel Blockers 2. Intravenous
Interventions:
Compression therapy for prevention of post‐thrombotic syndrome
1. Compression Therapy
Interventions:
Interventions for treating tuberculous pericarditis
1. Chemotherapy 2. Corticosteroids - Otological 3. Immunostimulants
Interventions:
Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome
1. Drug Eluding Stent
Interventions:
Treadmill training and body weight support for walking after stroke
1. Treadmill 2. Body Support
Interventions:
Pharmacotherapy for hypertension in adults aged 18 to 59 years
1. Diuretic 2. Centrally Acting Sympathomimetics 3. Calcium Channel Blockers 4. Beta Blocking Agent 5. Alpha 1 adrenergic blocking agent 6. Alpha And Beta Blocking Agents 7. Hydralazine 8. Minoxidil 9. Angiotensin-converting enzyme inhibitor 10. Alpha-adrenoreceptor Antagonists 11. Angiotensin II Antagonists, Plain
Interventions:
Blood pressure targets for hypertension in older adults
1. Blood Pressure Monitoring
Interventions:
Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization
1. Low Molecular Weight Heparin
Interventions:
Vitamin K antagonists versus low‐molecular‐weight heparin for the long term treatment of symptomatic venous thromboembolism
1. Vitamin K Antagonists
Interventions:
Occupational therapy for adults with problems in activities of daily living after stroke
1. Occupational Therapy 2. Daily Living Activity Therapy
Interventions:
Early supported discharge services for people with acute stroke
1. Accelerate Hospital Discharge
Interventions:
Psychological interventions for acute pain after open heart surgery
1. Cognitive Behavioral Therapy 2. Psychoeducation 3. Relaxation Therapy Session
Interventions:
Niacin for primary and secondary prevention of cardiovascular events
1. Lipid Modifying Agents 2. Nicotinic Acid
Interventions:
Growth factors for angiogenesis in peripheral arterial disease
1. Growth Factor
Interventions:
Circuit class therapy for improving mobility after stroke
1. Exercise Class 2. Exercise Circuits
Interventions:
Laparoscopic surgery for elective abdominal aortic aneurysm repair
1. Laparoscopy
Interventions:
Complete versus culprit‐only revascularisation in ST elevation myocardial infarction with multi‐vessel disease
1. Percutaneous Coronary Intervention 2. Myocardial Revascularization
Interventions:
Nitric oxide donors (nitrates), L‐arginine, or nitric oxide synthase inhibitors for acute stroke
1. Arginine 2. Nitric Oxide Synthase Inhibitors 3. Nitric Oxide
Interventions:
Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation
1. Self-monitoring 2. Biofeedback Procedure 3. Motivational Interviewing Technique 4. Cognitive Behavioral Therapy 5. Patient Education
Interventions:
Blood pressure lowering efficacy of renin inhibitors for primary hypertension
1. Renin-inhibitors
Interventions:
Low‐molecular‐weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke
1. Heparinoids 2. Low Molecular Weight Heparin
Interventions:
Exercise‐based cardiac rehabilitation in heart transplant recipients
1. Physical therapy exercises
Interventions:
Continuous chest compression versus interrupted chest compression for cardiopulmonary resuscitation of non‐asphyxial out‐of‐hospital cardiac arrest
1. Cardiopulmonary Resuscitation 2. Out of Hospital 3. Continuous Administration 4. Chest Wall Procedure
Interventions:
Vitamin C supplementation for the primary prevention of cardiovascular disease
1. Vitamin C
Interventions:
Risk scoring for the primary prevention of cardiovascular disease
1. Risk Assessment
Interventions:
Fixed‐dose combination therapy for the prevention of atherosclerotic cardiovascular diseases
1. Combination Therapy
Interventions:
Eplerenone for hypertension
1. Eplerenone 2. Oral
Interventions:
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism
1. Low Molecular Weight Heparin Therapy
Interventions:
Ranolazine for stable angina pectoris
1. Ranolazine
Interventions:
Beta‐blockers for hypertension
1. Beta Blocking Agent
Interventions:
Pharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic aneurysm
1. Lipid-lowering Therapy 2. Antiplatelet Agent Therapy 3. Antihypertensive agents
Interventions:
Stem cell therapy for chronic ischaemic heart disease and congestive heart failure
1. Cardiovascular Surgical Procedure 2. Autologous Peripheral Blood Stem Cell Transplant
Interventions:
Caregiver‐mediated exercises for improving outcomes after stroke
1. Physical therapy exercises 2. Carer
Interventions:
Blood pressure‐lowering efficacy of reserpine for primary hypertension
1. Rauwolfia Preparation 2. Reserpine
Interventions:
Interventions to improve adherence to lipid‐lowering medication
1. Reinforcement Of Adherence To Treatment Regimen
Interventions:
Oxygen therapy for acute myocardial infarction
1. Oxygen Gas For Inhalation
Interventions:
Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins
1. Ultrasound Guided Foam Sclerotherapy For Varicose Vein Of Leg 2. Radiofrequency Endometrial Ablation 3. Endovenous laser ablation of varicose vein
Interventions:
Efficacy and safety of ablation for people with non‐paroxysmal atrial fibrillation
1. Radiofrequency Ablation Device
Interventions:
Fibrates for primary prevention of cardiovascular disease events
1. Fibrates
Interventions:
Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis
1. Pharmacomechanical thrombectomy
Interventions:
Pharmacological interventions other than botulinum toxin for spasticity after stroke
1. Drug Therapy
Interventions:
Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm
1. Oral 2. Antiplatelet agent
Interventions:
Self management programmes for quality of life in people with stroke
1. Self-management
Interventions:
Venous cutdown versus the Seldinger technique for placement of totally implantable venous access ports
1. Venous Cutdown
Interventions:
Intravenous heparin during ruptured abdominal aortic aneurysmal repair
1. Intravenous 2. Heparin
Interventions:
Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs
1. Peripheral angioplasty balloon catheter, drug-eluting
Interventions:
Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy
1. Diuretic 2. Angiotensin II Antagonists 3. Beta Blocking Agent 4. Digitalis Preparation 5. Vasodilators Used In Cardiac Diseases 6. Aldosterone Antagonists 7. Other Cardiac Stimulants 8. Inotropic agent 9. Ace Inhibitors And Diuretics
Interventions:
Sulodexide for treating venous leg ulcers
1. Compression Therapy 2. Sulodexide
Interventions:
Routine invasive strategies versus selective invasive strategies for unstable angina and non‐ST elevation myocardial infarction in the stent era
1. Angiography
Interventions:
Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope
1. Implantation Of Insertable Loop Recorder
Interventions:
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
1. Antithrombotic Agents
Interventions:
Pre‐hospital versus in‐hospital initiation of cooling for survival and neuroprotection after out‐of‐hospital cardiac arrest
1. Cooling Of Intravenous Fluid 2. Pre-admission
Interventions:
Blood pressure lowering efficacy of beta‐1 selective beta blockers for primary hypertension
1. Nebivolol 2. Betaxolol 3. Practolol 4. Metoprolol 5. Esmolol 6. Beta Blocking Agents, Selective 7. Bisoprolol 8. Atenolol 9. Bevantolol
Interventions:
Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals
1. Diuretic 2. Centrally Acting Sympathomimetics 3. Calcium Channel Blockers 4. Renin-inhibitors 5. Beta Blocking Agent 6. Vasodilators Used In Cardiac Diseases 7. ACE Inhibitors, Plain 8. Alpha And Beta Blocking Agents 9. Alpha-adrenergic blocking agent 10. Antihypertensive agents 11. Angiotensin II Antagonists, Plain
Interventions:
Interventions for helping people adhere to compression treatments for venous leg ulceration
1. Venous Leg Ulcer Care Education 2. Social Support 3. Compression Therapy 4. Health System Guidance 5. Self-care Patient Education
Interventions:
Calcium channel blockers for primary Raynaud's phenomenon
1. Calcium Channel Blockers 2. Oral
Interventions:
Sexual counselling for sexual problems in patients with cardiovascular disease
1. Psychosexual Counseling
Interventions:
Oral aspirin for treating venous leg ulcers
1. Aspirin 2. Compression Therapy 3. Oral
Interventions:
Biphasic versus monophasic waveforms for transthoracic defibrillation in out‐of‐hospital cardiac arrest
1. Biphasic Defibrillation Procedure
Interventions:
Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular disease
1. Assessment For Risk Of Cardiovascular Disease
Interventions:
Warfarin initiation nomograms for venous thromboembolism
1. Warfarin
Interventions:
Perioperative angiotensin‐converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults
1. Perioperative 2. Angiotensin-converting enzyme inhibitor 3. Angiotensin II Antagonists, Plain
Interventions:
Colchicine for prevention of cardiovascular events
1. Colchicine
Interventions:
A 'test and treat' strategy for elevated wound protease activity for healing in venous leg ulcers
1. Adult Screening 2. Protease Modulating Matrix Treatment
Interventions:
Internet‐based interventions for the secondary prevention of coronary heart disease
1. Health Promotion 2. Computer delivered intervention
Interventions:
Nurse‐led titration of angiotensin converting enzyme inhibitors, beta‐adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction
1. Angiotensin II Receptor Antagonist Therapy 2. ACE inhibitor therapy 3. Beta Adrenergic Receptor Blocking Agent Therapy 4. Nurse
Interventions:
Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death
1. Amiodarone
Interventions:
Aminophylline for bradyasystolic cardiac arrest in adults
1. Intravenous 2. Aminophylline
Interventions:
Structured telephone support or non‐invasive telemonitoring for patients with heart failure
1. Telephone Follow-up
Interventions:
Fibrates for secondary prevention of cardiovascular disease and stroke
1. Fibrates
Interventions:
Implantable defibrillators versus medical therapy for cardiac channelopathies
1. Implantable Defibrillator
Interventions:
Stent graft types for endovascular repair of thoracic aortic aneurysms
1. Endovascular Insertion Of Stent Graft
Interventions:
Debridement for venous leg ulcers
1. Debridement
Interventions:
Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack
1. Transcatheter Device Closure
Interventions:
Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension
1. Alpha- And Beta-adrenoreceptor Agonists 2. Carvedilol 3. Labetalol
Interventions:
Prophylactic lidocaine for myocardial infarction
1. Lidocaine
Interventions:
Buflomedil for acute ischaemic stroke
1. Buflomedil
Interventions:
Negative pressure wound therapy for treating leg ulcers
1. Negative Pressure Wound Dressing
Interventions:
Fresh frozen plasma for cardiovascular surgery
1. Fresh Frozen Plasma Transfusion
Interventions:
Psychosocial interventions for smoking cessation in patients with coronary heart disease
1. Smoking Cessation Assistance 2. Smoking Cessation Therapy 3. Smoking Cessation Education
Interventions:
Interventions for post‐stroke fatigue
1. Non-Pharmacological Interventions 2. Drug Therapy
Interventions:
Psychological interventions for symptomatic management of non‐specific chest pain in patients with normal coronary anatomy
1. Hypnotherapy 2. Counseling 3. Psychotherapy 4. Cognitive Behavioral Therapy 5. Relaxation Therapy Session
Interventions:
Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery
1. Parenteral 2. Oral 3. Anticoagulant therapy
Interventions:
Motivational interviewing for improving recovery after stroke
1. Motivational Interviewing Technique
Interventions:
Anti‐inflammatory treatment for carditis in acute rheumatic fever
1. Non-steroidal Anti-inflammatory Drug 2. Aspirin 3. Anabolic Steroids
Interventions:
Blood pressure‐lowering efficacy of loop diuretics for primary hypertension
1. Loop diuretic
Interventions:
Adenosine and verapamil for no‐reflow during primary percutaneous coronary intervention in people with acute myocardial infarction
1. Adenosine 2. Verapamil
Interventions:
Influenza vaccines for preventing cardiovascular disease
1. Influenza Virus Vaccine
Interventions:
Intra‐aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock
1. Intra-aortic Balloon Catheter Operation
Interventions:
Anaesthetic and sedative agents used for electrical cardioversion
1. General inhalation anesthetic 2. Hypnotics And Sedatives 3. Intravenous Anesthesia
Interventions:
Interventions for improving community ambulation in individuals with stroke
1. Community-Based 2. Ambulation Therapy
Interventions:
Atorvastatin for lowering lipids
1. Atorvastatin
Interventions:
HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass
1. Preventive 2. Perioperative 3. Statins
Interventions:
Transmyocardial laser revascularization versus medical therapy for refractory angina
1. Myocardial Revascularization
Interventions:
Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery
1. Antiplatelet Agent Therapy
Interventions:
Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardia
1. Therapeutic Procedure
Interventions:
Beta‐adrenergic blockers for perioperative cardiac risk reduction in people undergoing vascular surgery
1. Beta Blocking Agent
Interventions:
Statins for primary prevention of venous thromboembolism
1. Statin Prophylaxis
Interventions:
Biologics, colchicine, corticosteroids, immunosuppressants and interferon‐alpha for Neuro‐Behçet's Syndrome
1. Immunosuppressant 2. Corticosteroids - Otological 3. Biological agent 4. Colchicine 5. Interferon Alfa
Interventions:
Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis
1. Balloon Angioplasty Of Renal Artery
Interventions:
Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension
1. Bopindolol 2. Celiprolol 3. Alprenolol 4. Acebutolol 5. Oxprenolol 6. Pindolol
Interventions:
Rosuvastatin for lowering lipids
1. Rosuvastatin
Interventions:
Interventions for deliberately altering blood pressure in acute stroke
1. Loop diuretic 2. Angiotensin II Antagonists 3. ACE Inhibitors, Plain 4. Vasoconstrictor agents 5. Prostacyclin 6. Nitric Oxide 7. Alpha-adrenoreceptor Antagonists 8. Vinpocetine 9. Naftidrofuryl 10. Pentoxifylline 11. Calcium Channel Blockers 12. Beta Blocking Agent 13. H2-receptor Antagonists 14. Serotonin Antagonists 15. Incretin Mimetic 16. Thiazides 17. Thiazide diuretic 18. Target-driver blood pressure lowering 19. Sympathomimetic agent 20. Theophylline 21. Papaverine And Derivatives
Interventions:
Cardiopulmonary resuscitation (CPR) plus delayed defibrillation versus immediate defibrillation for out‐of‐hospital cardiac arrest
1. Cardiopulmonary Resuscitation 2. Delayed Treatment 3. Direct Current Defibrillation
Interventions:
Pre‐hospital versus in‐hospital thrombolysis for ST‐elevation myocardial infarction
1. Pre-hospital care 2. Thrombolysis
Interventions:
Time course for blood pressure lowering of dihydropyridine calcium channel blockers
1. Dihydropyridine Derivatives
Interventions:
Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension
1. ACE inhibitor therapy 2. Angiotensin II Antagonists, Plain
Interventions:
Exercise for people with high cardiovascular risk
1. Nutrition Therapy 2. Exercise 3. Drug Therapy
Interventions:
Heparin versus placebo for non‐ST elevation acute coronary syndromes
1. Heparin
Interventions:
Angioplasty versus bare metal stenting for superficial femoral artery lesions
1. Angioplasty
Interventions:
Anticoagulation therapy versus placebo for pulmonary hypertension
1. Warfarin 2. Fondaparinux 3. Argatroban 4. Heparin
Interventions:
Blood pressure‐lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
1. Thiazide diuretic
Interventions:
Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection
1. Trypanocidal Agents 2. Oral
Interventions:
Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication
1. Anticoagulant therapy
Interventions:
Type of incision for below knee amputation
1. Long Posterior Flap Incision
Interventions:
Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non‐valvular atrial fibrillation
1. Direct Thrombin Inhibitors
Interventions:
Glycoprotein IIb‐IIIa inhibitors for acute ischaemic stroke
1. RTS.S/AS02D 2. Varicella Zoster Virus Glycoprotein E, Recombinant
Interventions:
Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis
1. Antibiotic Prophylaxis
Interventions:
Combined oral contraceptives: venous thrombosis
1. Desogestrel / Ethinyl Estradiol Oral Tablet 2. Ethinyl Estradiol / Norgestrel Oral Tablet 3. Progestogens And Estrogens Systemic Contraceptives, Sequential Preparations 4. Norethisterone And Ethinylestradiol 5. Ethinyl Estradiol / Levonorgestrel Oral Tablet 6. Cyproterone / Ethinyl Estradiol Oral Tablet 7. Ethinyl Estradiol / Gestodene Oral Tablet 8. Progestogens And Estrogen Systemic Contraceptives, Fixed Combinations 9. Ethinyl Estradiol / Lynestrenol Oral Tablet 10. Drospirenone / Estradiol Oral Tablet
Interventions:
Blood pressure lowering efficacy of nonselective beta‐blockers for primary hypertension
1. Beta Blocking Agents, Non-selective
Interventions:
First‐line beta‐blockers versus other antihypertensive medications for chronic type B aortic dissection
1. Beta Blocking Agent
Interventions:
Insulin for glycaemic control in acute ischaemic stroke
1. Insulins and analogues
Interventions:
Endovascular repair of abdominal aortic aneurysm
1. Endovascular Repair Of Abdominal Aortic Aneurysm
Interventions:
Antibiotics and antiseptics for venous leg ulcers
1. Antiseptics 2. Antibiotic Therapy
Interventions:
Intravascular brachytherapy for peripheral vascular disease
1. Intravascular brachytherapy 2. Percutaneous Transluminal Angioplasty
Interventions:
Treatment of hypertension in peripheral arterial disease
1. Drug Therapy
Interventions:
Immunosuppressive T‐cell antibody induction for heart transplant recipients
1. Immunosuppressive Therapy
Interventions:
Blood pressure targets for hypertension in people with diabetes mellitus
1. Targeted Therapy
Interventions:
Corticosteroids for viral myocarditis
1. Corticosteroids
Interventions:
Beta blockers for peripheral arterial disease
1. Beta Blocking Agents, Selective
Interventions:
Nitrates for acute heart failure syndromes
1. Nitroglycerin 2. Isosorbide Dinitrate
Interventions:
Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism
1. Subcutaneous 2. Low Molecular Weight Heparin
Interventions:
Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post‐stroke spasticity
1. Botulinum Toxin 2. Intramuscular 3. Drug Therapy 4. Multidisciplinary rehabilitation
Interventions:
Occupational therapy for care home residents with stroke
1. Occupational Therapy 2. Residential Home
Interventions:
Early versus delayed mobilisation for aneurysmal subarachnoid haemorrhage
1. Delayed Treatment 2. Therapeutic mobilization
Interventions:
Continuous versus intermittent physiological monitoring for acute stroke
1. Continuous physiological monitoring
Interventions:
Flavonoids for treating venous leg ulcers
1. Compression Bandaging 2. Flavonoids
Interventions:
Cholesterol‐reducing agents for aneurysmal subarachnoid haemorrhage
1. Lipid Modifying Agents
Interventions:
Non‐pharmacological interventions for preventing secondary vascular events after stroke or transient ischemic attack
1. Non-Pharmacological Interventions
Interventions:
Physical rehabilitation for older people in long‐term care
1. Long Term Care Facility 2. Physical Rehabilitation Therapy Procedure
Interventions:
Hypothermia for neuroprotection in children after cardiopulmonary arrest
1. Hypothermia Treatment
Interventions:
Wolbachia‐carrying Aedes mosquitoes for preventing dengue infection
1. Mosquito control measures 2. Mosquito-borne Wolbachia transmission
Interventions:
Vaccines for preventing herpes zoster in older adults
1. Preventive 2. Varicella Zoster Vaccines
Interventions:
Antiplatelet agents for the treatment of adults with COVID‐19
1. Antiplatelet agent
Interventions:
Balanced crystalloid solutions versus 0.9% saline for treating acute diarrhoea and severe dehydration in children
1. Crystalloids
Interventions:
Therapeutics for treating mpox in humans
1. Immunoglobulins 2. Tecovirimat 3. Cidofovir 4. Brincidofovir 5. Immunomodulators
Interventions:
Hyperimmune immunoglobulin for people with COVID‐19
1. Hyperimmune immunoglobulin
Interventions:
Remdesivir for the treatment of COVID‐19
1. Remdesivir
Interventions:
Systemic corticosteroids for the treatment of COVID‐19: Equity‐related analyses and update on evidence
1. Corticosteroids - Systemic use 2. Usual Care
Interventions:
Ivermectin for preventing and treating COVID‐19
1. Ivermectin
Interventions:
SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19
1. SARS-CoV-2 monoclonal antibodies
Interventions:
Janus kinase inhibitors for the treatment of COVID‐19
1. Usual Care 2. Janus kinase inhibitor
Interventions:
Inhaled corticosteroids for the treatment of COVID‐19
1. Corticosteroids 2. Inhaled
Interventions:
Antibiotics for the treatment of COVID‐19
1. Clarithromycin 2. Lincomycin 3. Azithromycin 4. Doxycycline
Interventions:
Colchicine for the treatment of COVID‐19
1. Colchicine 2. Usual Care
Interventions:
SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19
1. Monoclonal Antibodies
Interventions:
Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV
1. Lateral flow urine lipoarabinomannan assay 2. Screening Procedure
Interventions:
Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta‐analysis
1. Transurethral Microwave Thermotherapy To Prostate 2. Prostatic arterial embolization 3. Connective Radiofrequency Water Vapour Thermal Therapy 4. Prostatic urethral lift procedure 5. Temporary Implantable Nitinol Device
Interventions:
Effect of mass deworming with antihelminthics for soil‐transmitted helminths during pregnancy
1. Anthelmintic
Interventions:
Topical microbicides for preventing sexually transmitted infections
1. Microbicides 2. Topical
Interventions:
Topical antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving mechanical ventilation
1. Preventive 2. Antibiotic Prophylaxis 3. Topical
Interventions:
Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID‐19 infection
1. Mouthwash 2. Nasal 3. Antimicrobials
Interventions:
Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID‐19 infection to improve patient outcomes and to protect healthcare workers treating them
1. Mouthwash 2. Nasal 3. Antimicrobials
Interventions:
Video calls for reducing social isolation and loneliness in older people: a rapid review
1. Video calling
Interventions:
Shortened treatment regimens versus the standard regimen for drug‐sensitive pulmonary tuberculosis
1. Shortened treatment regime 2. Drugs For Treatment Of Tuberculosis
Interventions:
Antibiotics for asymptomatic bacteriuria in pregnancy
1. Antibacterials For Systemic Use
Interventions:
Intra‐pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema
1. Urokinase 2. Streptokinase 3. Alteplase 4. Intrapleural
Interventions:
Rapid initiation of antiretroviral therapy for people living with HIV
1. Antiviral Therapy
Interventions:
Community‐based antibiotic delivery for possible serious bacterial infections in neonates in low‐ and middle‐income countries
1. Community-Based 2. Antibacterials For Systemic Use 3. Newborn Care Management 4. Injection 5. Oral
Interventions:
Primary antifungal prophylaxis for cryptococcal disease in HIV‐positive people
1. Primary antifungal prophylaxis
Interventions:
Early versus delayed antiretroviral treatment in HIV‐positive people with cryptococcal meningitis
1. Early Treatment 2. Antiretroviral Therapy
Interventions:
Influenza vaccine for chronic obstructive pulmonary disease (COPD)
1. Influenza Virus Vaccine
Interventions:
Interventions for necrotizing soft tissue infections in adults
1. Anti-bacterial agent 2. Debridement 3. Adjunctive Care 4. Amputation 5. Removal Of Soft Tissue 6. Antibiotic Therapy 7. Antifungals For Dermatological Use
Interventions:
Interventions to increase influenza vaccination rates of those 60 years and older in the community
1. Influenza Virus Vaccine 2. Immunization Education
Interventions:
Osmotic therapies added to antibiotics for acute bacterial meningitis
1. Osmotic diuretic 2. Intravenous Antibiotic Therapy
Interventions:
Antidepressants for depression in adults with HIV infection
1. Antidepressants
Interventions:
Corticosteroids for pneumonia
1. Corticosteroids - Systemic use 2. Antibiotic Therapy
Interventions:
Macrolides for treatment of Haemophilus ducreyi infection in sexually active adults
1. Macrolides
Interventions:
Interventions to increase tuberculosis case detection at primary healthcare or community‐level services
1. Screening Case Management 2. Tuberculosis Screening
Interventions:
Routine antibiotic prophylaxis after normal vaginal birth for reducing maternal infectious morbidity
1. Antibiotic Prophylaxis
Interventions:
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
1. Antibacterials For Systemic Use 2. Calcitonin Measurement
Interventions:
Short‐course versus long‐course intravenous therapy with the same antibiotic for severe community‐acquired pneumonia in children aged two months to 59 months
1. Antibacterials For Systemic Use 2. Intravenous
Interventions:
Intravenous immunoglobulin for the treatment of childhood encephalitis
1. Immunoglobulins 2. Intravenous 3. Usual Care
Interventions:
Probiotics for preventing urinary tract infection in people with neuropathic bladder
1. Preventive 2. Probiotics
Interventions:
Isoniazid for preventing tuberculosis in HIV‐infected children
1. Drugs For Treatment Of Tuberculosis
Interventions:
Antibiotics for persistent cough or wheeze following acute bronchiolitis in children
1. Antibacterials For Systemic Use
Interventions:
Zinc supplementation for the treatment of measles in children
1. Usual Care 2. Zinc
Interventions:
Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease
1. Preventive 2. Oral 3. Non-typeable Haemophilus Influenzae Vaccine
Interventions:
Antibiotics for acute bronchitis
1. Anti-bacterial agent
Interventions:
Pre‐admission antibiotics for suspected cases of meningococcal disease
1. Pre-admission 2. Antibiotic Therapy
Interventions:
Nasal decontamination for the prevention of surgical site infection in Staphylococcus aureus carriers
1. Antiseptics And Disinfectants 2. Nasal 3. Antibiotics For Topical Use
Interventions:
Surgical versus non‐surgical management for pleural empyema
1. Video Assisted Thoracoscopy 2. Thoracotomy
Interventions:
Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock
1. Procalcitonin measurement
Interventions:
Dressings for the prevention of surgical site infection
1. Surgical tissue adhesive 2. Gauze Dressing 3. Wound Management Dressing 4. Adhesive Tape 5. Medical Dressing 6. Surgical Dressings 7. Wound dressing 8. Wound And Ulcer Preparations 9. Application Of Antimicrobial Dressing
Interventions:
Antiviral agents for infectious mononucleosis (glandular fever)
1. Antivirals
Interventions:
One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates
1. Gentamicin
Interventions:
School‐based interventions for preventing HIV, sexually transmitted infections, and pregnancy in adolescents
1. School
Interventions:
Topical antibiotics for preventing surgical site infection in wounds healing by primary intention
1. Antibiotics For Topical Use
Interventions:
Fluid therapy for acute bacterial meningitis
1. Fluid therapy
Interventions:
Antibiotics for ventilator‐associated pneumonia
1. Antibacterials For Systemic Use
Interventions:
HIV prevention advice for people with serious mental illness
1. HIV Prevention Education
Interventions:
Interventions for men and women with their first episode of genital herpes
1. Administration Of Drug Or Medicament To Skin Via Topical Route 2. Plant Alkaloids And Other Natural Products 3. Imiquimod 4. Antivirals 5. Interferon 6. Antivirals For Systemic Use
Interventions:
Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults
1. Influenza Virus Vaccine 2. Prophylaxis 3. Physical therapy exercises
Interventions:
Behavioral interventions for improving contraceptive use among women living with HIV
1. Emergency Contraception Education 2. Contraception Care Education 3. Condom Use Education 4. Contraception Education 5. Contraceptive Use Education 6. Sterilization Education 7. Education About Oral Contraception 8. Progestogen Only Oral Contraceptive Education 9. Contraceptive Implant Education 10. Counseling For Intrauterine Device Contraception
Interventions:
Corticosteroids for treating nerve damage in leprosy
1. Corticosteroids - Opthamological and Otological 2. Prednisone 3. Methylprednisolone 4. Prednisolone
Interventions:
Antiepileptic drugs for the primary and secondary prevention of seizures in viral encephalitis
1. Antiepileptics
Interventions:
Fixed‐dose combinations of drugs versus single‐drug formulations for treating pulmonary tuberculosis
1. Chemotherapy 2. Fixed dose combination chemotherapy
Interventions:
Systemic antifungal therapy for tinea capitis in children
1. Ketoconazole 2. Fluconazole 3. Azole antifungal 4. Systemic 5. Griseofulvin 6. Terbinafine 7. Itraconazole 8. Antifungals For Dermatological Use